Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 1.00 |
| ▸ | CNR1 | P21554 | 12/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 2/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 2/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 1/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 1/20 | 1.00 |
| ▸ | CYP2J2 | P51589 | 1/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 1.00 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabinol SCHEMBL29815206 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL23460333 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL29433714 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL29350505 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29814997 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL24714648 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL28565069 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL24713687 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| SCHEMBL29814956 | 0.99 | CNR2 (0.98) | CNR2CNR1TRPA1TRPV1TRPV3 | |
| Cannabinol SCHEMBL16061830 | 0.97 | CNR2 (0.93) | CNR2CNR1TRPA1TRPV1TRPV3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 17551 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4412609-B1 | ALKOXYLATION OF CANNABIDIOL & OTHER CANNABINOIDS | INDORAMA VENTURES OXIDES LLC (US) | 2026-05-27 | — | — | EP | claimed |
| US-12636294-B2 | Compositions and methods for the treatment or prevention of traumatic brain injury | Incannex Healthcare Limited (AU) | 2026-05-26 | — | — | US | claimed |
| US-12636296-B1 | Cannabinol analogs and their use as pharmacologically active agents | NALU BIO, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| EP-4743180-A1 | 3-HYDROXYPROPYLESTERS AS ANTIOXIDANTS AND TOCOPHEROL BOOSTERS | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4041390-B1 | CANNABIDIOL AND ISOFLURANE FOR THE TREATMENT OR PREVENTION OF TRAUMATIC BRAIN INJURY | INCANNEX HEALTHCARE LTD (AU) | 2026-05-20 | — | — | EP | claimed |
| US-12629383-B2 | Cannabinoid compositions with high solubility and bioavailability | PISAK MEHMET NEVZAT (TR) | 2026-05-19 | — | — | US | claimed |
| EP-4604746-B1 | ORAL PRODUCT COMPRISING THEOBROMINE | CONTRAF NICOTEX TOBACCO GMBH (DE) | 2026-05-13 | — | — | EP | claimed |
| EP-4739284-A1 | AN ADHESIVE ORAL DISC FOR SUSTAINED RELEASE OF CANNABINOIDS | Fertin Pharma A/S (DK) | 2026-05-13 | — | — | EP | claimed |
| EP-4740961-A2 | CANNABINOID PRODUCT FOR IMPROVING MUSCULOSKELETAL HEALTH | Lonza Greenwood LLC (US) | 2026-05-13 | — | — | EP | claimed |
| EP-1109533-A1 | PULMONARY DELIVERY OF LIPOSOME-ENCAPSULATED CANNABINOIDS | Hung, Orlando (CA) | 2001-06-27 | — | — | EP | claimed |
| WO-2001003668-A1 | PULMONARY DELIVERY OF LIPOSOME-ENCAPSULATED CANNABINOIDS | HER MAJESTY THE QUEEN AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 2001-01-18 | — | — | WO | claimed |
| WO-2000056303-A2 | TREATMENT OF IMMUNE DISEASES | IMMUGEN PHARMACEUTICALS, INC. (US) | 2000-09-28 | — | — | WO | claimed |
| US-5440052-A | Compositions useful as a cannabinoid receptor probe | UNIVERSITY OF CONNECTICUT (US) | 1995-08-08 | — | — | US | claimed |
| EP-0276732-B1 | Novel cannabinol derivatives and improved immunoassay | HOFFMANN LA ROCHE (CH) | 1993-12-01 | — | — | EP | claimed |
| US-5219747-A | Cannabinol derivatives | HOFFMANN-LA ROCHE INC. (US) | 1993-06-15 | — | — | US | claimed |
| US-4833073-A | Immunoassay for tetrahydrocannabinol metabolites | HOFFMANN-LA ROCHE INC. (US) | 1989-05-23 | — | — | US | claimed |
| EP-0276732-A2 | Novel cannabinol derivatives and improved immunoassay | F. HOFFMANN-LA ROCHE AG (CH) | 1988-08-03 | — | — | EP | claimed |
| US-4353886-A | DETECTION OF NARCOTIC VAPORS BY COMPLEXING WITH ANTIBODY | IRT CORPORATION (US) | 1982-10-12 | — | — | US | claimed |
| US-4233030-A | Methods and apparatus for liquid chromatography | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1980-11-11 | — | — | US | claimed |